Novartis AG 2014 SR
The report highlights Novartis' 2014 performance in corporate responsibility, focusing on expanding access to healthcare and ethical business practices. Key achievements include reaching over 1 billion patients globally and delivering 700 million malaria treatments without profit since 2001. The company underwent a major portfolio transformation and strengthened its ESG governance by creating a Board-level committee. Environmental progress was noted with a 12.1% reduction in greenhouse gas emissions since 2008. Additionally, Novartis improved its ranking to fourth in the Access to Medicine Index.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2014
Type: SR
Pages: 84
Back to company
Novartis AG
Corporate Responsibility Performance Report
The report highlights Novartis' 2014 performance in corporate responsibility, focusing on expanding access to healthcare and ethical business practices. Key achievements include reaching over 1 billion patients globally and delivering 700 million malaria treatments without profit since 2001. The company underwent a major portfolio transformation and strengthened its ESG governance by creating a Board-level committee. Environmental progress was noted with a 12.1% reduction in greenhouse gas emissions since 2008. Additionally, Novartis improved its ranking to fourth in the Access to Medicine Index.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees